InMed Pharmaceuticals Inc. announced that Dr. Sazzad Hossain, PhD, MSc, will assume a position as member of the Scientific Advisory Board and, contemporaneously, announced his retirement as Chief Scientific Officer. Dr. Eric C. Hsu, PhD, Vice President, Pre-Clinical Research & Development, will continue to lead the scientific R&D programs of the Company.